Tim Edmonds: Blood Cancer NZ CEO on Pharmac considering funding two new blood cancer treatments
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Tim Edmonds: Blood Cancer NZ CEO on Pharmac considering funding two new blood cancer treatments
-
Narrated by:
-
By:
About this listen
Two new blood cancer medications could soon be available to patients as pills, with one accessible through private clinics.
Pharmac will consider funding treatments for chronic lymphocytic leukaemia, which could be available from May 1st.
They can be taken in pill form and take away the need for chemotherapy.
Blood Cancer NZ CEO Tim Edmonds told Ryan Bridge the medications take a targeted approach to first-line treatment, which means they’ll be able to access targeted therapy instead of chemotherapy once diagnosed.
He says instead of visiting the hospital up to 20 times in six months, they can take an oral tablet every day from home and actually get better outcomes.
LISTEN ABOVE
See omnystudio.com/listener for privacy information.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.